Brief: Calidi Biotherapeutics Inc Files For Mixed Shelf Offering Of Up To $25 Million - SEC Filing
01/10/2024 22:13
Calidi Biotherapeutics Inc CLDI.A :
* CALIDI BIOTHERAPEUTICS INC FILES FOR MIXED SHELF OFFERING
OF UP
TO $25 MILLION - SEC FILING
Source text for Eikon: ID:n0001493152-24-039049
Further company coverage: CLDI.A
Recent news on Calidi Biotherapeutics
See all newsBrief: Calidi Biotherapeutics Announces Strategic Partnership With Transferai
Brief: Calidi Biotherapeutics Announces Partnership With Avance Clinical To Facilitate Australian Regulatory Approval
Brief: Calidi Biotherapeutics Announces Pricing Of $5.2 Million Underwritten Public Offering
Brief: Calidi Biotherapeutics Eliminates Chief Legal Officer Position - SEC Filing
Brief: Calidi Biotherapeutics Receives FDA Fast Track Designation For Cld-201 (Supernova), A First-In-Class Stem-Cell Loaded Viral Therapy For The Treatment Of Patients With Soft Tissue Sarcoma